Amitriptyline as a reference antidepressant. r ational pharmacotherapy for depression with chronic pain and insomnia-Reference-Cited by-同舟云学术

Amitriptyline as a reference antidepressant. r ational pharmacotherapy for depression with chronic pain and insomnia

Published:2022-07-25 Issue:8 Volume: Page:35-38
ISSN:
Container-title:Glavvrač (Chief Medical Officer)
language:
Short-container-title:Chief Medical Officer

Author:

Akhmedzhanova A.D., ,Maksimov M. L.,

Abstract

According to WHO, depressive disorders are 4 times more common among patients suffering from chronic pain with insomnia. Insomnia in depression complicated by pain is a clinical syndrome characterized by nocturnal sleep disorders and related disorders during daytime wakefulness, occurring even when there is sufficient time and conditions for sleep. Treatment of insomnia patients with amitriptyline, phenazepam, and bromocamphor reduced the average duration of hospitalization, improved the patients’ quality of life, and reduced the frequency of seeking neurological care.

Publisher

PANORAMA Publishing House

Reference5 articles.

1. 1. Helmchen H. Gestuften Vorgehen bei Resistenz gegen Antidepressiva - Therapie. In: Muller HJ (ed) Therapiesistenz under Antidepressiva-Behandlung. 1990. New York, 237-250.

2. 2. Ratsionalnaia farmakoterapiia depressii, oslozhnennoi nevrologicheskoi simptomatikoi: khronicheskoi boliu i insomniei [Rational pharmacotherapy of depression complicated by neurological symptoms: chronic pain and insomnia] /Maksimov M. L., Kuchaeva A. V. / Russkii meditsinskii zhurnal [Russian Medical Journal] (31.10.2018) URL: https://www.rmj.ru/articles/nevrologiya/Racionalynaya_farmakoterapi-ya_depressii_osloghnennoy_nevrologicheskoy_simptomatikoy_hronicheskoy_bolyyu_i_insomniey/. (In Russ.)

3. 3. Effektivnost i bezopasnost monoterapii antidepressantami endogennykh iunosheskikh depressii [Ef¬ficacy and safety of antidepressant monotherapy for endogenous juvenile depression] (2011). / Ole¬ichik I. V., Kopeiko I. G. / URL: https://cyberleninka.ru/article/n/effektivnost-i-bezopasnost-monotera¬pii-antidepressantami-endogennyh-yunosheskih-depressiy. (In Russ.)

4. 4. Farmakodinamicheskii potentsial kombinatsii amitriptilina i venlafaksina (eksperimentalnoe issledo¬vanie) [Pharmacodynamic potential of the combination of amitriptyline and venlafaxine (experimental study)] (2013) / Gaiduk A. V., Bizunok N. A. https://cyberleninka.ru/article/n/farmakodinamicheskiy-po¬tentsial-kombinatsiy-atipichnogo-antidepressanta-mianserina-s-selektivnymi-ingibitorami-obratno¬go-zahvata. (In Russ.)

5. 5. Poluektov M. G. Klinicheskii algoritm diagnosticheskogo i lechebnogo vybora pri insomnii [Clinical al¬gorithm for diagnostic and therapeutic choice in insomnia] // Effektivnaia farmakoterapiia [Effective Pharmacotherapy]. 2016. № 12. P. 22-28. (In Russ.)